eftilagimod alpha,pembrolizumab
merck,immutep
['pembro', 'eftilagimod', 'tacti-002']
late breaking abstract 1470 wade iams presents interim results of tacti-002 a phase 2 combining apc activator eftilagimod alpha (soluble lag3) and pembro for 1st line #nsclc orr 40.4% dor 21.6 mos #sitc22 